These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 16605301)

  • 41. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
    Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
    Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
    Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
    Parasite; 2017; 24():34. PubMed ID: 28959938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment.
    Pivotto AP; de Souza Lima LB; Michelon A; Ferreira CZP; Gandra RF; Ayala TS; Menolli RA
    Med Microbiol Immunol; 2024 Mar; 213(1):4. PubMed ID: 38532203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the Glucantime Concentration for the
    Zorbozan O; Evren V; Harman M; Özbilgin A; Alkan Yılmaz Ö; Turgay N
    Turkiye Parazitol Derg; 2021 Dec; 45(4):237-240. PubMed ID: 34889188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan.
    Plourde M; Coelho A; Keynan Y; Larios OE; Ndao M; Ruest A; Roy G; Rubinstein E; Ouellette M
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1463. PubMed ID: 22272366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular-based detection of
    Vazin A; Heidaripour MS; Kalantari M; Hatam G
    J Parasit Dis; 2022 Jun; 46(2):328-333. PubMed ID: 35692465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Vitro and In Vivo Antileishmanial Activities of Pistacia vera Essential Oil.
    Mahmoudvand H; Saedi Dezaki E; Ezatpour B; Sharifi I; Kheirandish F; Rashidipour M
    Planta Med; 2016 Mar; 82(4):279-84. PubMed ID: 26829519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
    Gazola KC; Ferreira AV; Anacleto C; Michalick MS; Andrade AF; Moreira ES
    Parasitol Res; 2001 Nov; 87(11):935-40. PubMed ID: 11728019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica.
    Mostafavi M; Khazaeli P; Sharifi I; Farajzadeh S; Sharifi H; Keyhani A; Parizi MH; Kakooei S
    Korean J Parasitol; 2019 Feb; 57(1):1-8. PubMed ID: 30840792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
    Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
    Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimonial susceptibility and in vivo behaviour of Leishmania major isolates collected in Algeria before and after treatment.
    Naouel E; Ihcene KD; Sofiane B; Khatima AO; Razika B; Bruno O; Zoubir H; Denis S
    Acta Trop; 2018 Apr; 180():7-11. PubMed ID: 29278674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.
    Harms G; Chehade AK; Douba M; Roepke M; Mouakeh A; Rosenkaimer F; Bienzle U
    Trans R Soc Trop Med Hyg; 1991; 85(2):214-6. PubMed ID: 1909469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
    Oliaee RT; Sharifi I; Bamorovat M; Keyhani A; Babaei Z; Salarkia E; Tavakoly R; Khosravi A; Mostafavi M; Sharifi F; Mousavi SM
    Int Immunopharmacol; 2020 Sep; 86():106704. PubMed ID: 32590317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco].
    Hjira N; Frikh R; Marcil T; Lamsyah H; Oumakhir S; Baba N; Boui M
    Pan Afr Med J; 2014; 17():272. PubMed ID: 25309671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trypanothione Reductase Gene Mutations in Meglumine Antimoniate Resistant Isolates from Cutaneous Leishmaniasis Patients Using Molecular Dynamics Method.
    Fozongari F; Dalimi A; Arab SS; Behmanesh M; Khammari A
    Iran J Parasitol; 2020; 15(4):511-520. PubMed ID: 33884008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of
    Mahmoudvand H; Kheirandish F; Mirbadie SR; Kayedi MH; Rezaei Riabi T; Ghasemi AA; Bamorovat M; Sharifi I
    Iran J Parasitol; 2017; 12(3):339-347. PubMed ID: 28979343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.